Meeting
2023 ASCO Quality Care Symposium
Clinical pharmacist prescription review and modification for oral antineoplastic medications at an academic medical center.
Authors
Marina D. Kaymakcalan
Dana-Farber Cancer Institute, Boston, MA
Marina D. Kaymakcalan, Jenafer Thomas, Kristin Nowakowski, Shital Shukla, Anne C. Le, Christina Cibotti, Monica Syngal, Jim W Doolin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Team-Based Approaches to Care Delivery
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 64)
DOI
10.1200/OP.2023.19.11_suppl.64
Abstract #
64
Poster Bd #
C17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Does financial assistance reduce catastrophic spending for patients prescribed oral anti-cancer medications at an integrated Specialty Pharmacy?
First Author: Scott Swartz
Poster
2023 ASCO Quality Care Symposium
Time trends of Part D drug expenses and Part D risk adjustment in the Oncology Care Model at a community oncology network.
First Author: Puneeth Indurlal
Poster
2022 ASCO Quality Care Symposium
Between and within drug variation in copayments for common oral anti-cancer medications at an academic medical center.
First Author: Scott Swartz
Poster
2022 ASCO Quality Care Symposium
Creation of standard work for the management of outpatient oral antineoplastic therapy.
First Author: Junid Naveed Naveed Ahmad